Does the mesorectal fat area impact the histopathology metrics of the specimen in males undergoing TME for distal rectal cancer?
Daniel Moritz Felsenreich(Medical University of Vienna), Moshe Barnajian(Cedars-Sinai Medical Center), Guglielmo Niccolò Piozzi(Portsmouth Hospitals NHS Trust), Oktar Asoğlu(Mayo Clinic), Rosa M. Jiménez-Rodríguez(Hospital Universitario Virgen del Rocío), Roberto Bergamaschi(Jacobi Medical Center), Seon Hahn Kim(Korea University), Tomohiro Yamaguchi(Japanese Foundation For Cancer Research), Fabio Cianchi(Azienda Ospedaliero-Universitaria Careggi), Li‐Jen Kuo, Yosef Nasseri, Dejan Ignjatović, Vusal Aliyev, Mahir Gachabayov(Westchester Medical Center)
Cited by 11
Related Papers
Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system
|Cancer Science|2014|238
Risk Factors for Recurrence and Death After Primary Surgical Treatment of Malignant Phyllodes Tumors
|Annals of Surgical Oncology|2004|178
Male sexual dysfunction after rectal cancer surgery: Results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer: Japan Clinical Oncology Group Study JCOG0212
|European Journal of Surgical Oncology|2016|138
Learning curve for robotic-assisted surgery for rectal cancer: use of the cumulative sum method
|Surgical Endoscopy|2014|132
Open versus Laparoscopic Surgery for Advanced Low Rectal Cancer
|Annals of Surgery|2017|121